Superconductivity Surge Mobilizes Lab Chiefs

NEW YORK—A surge of new research in superconductivity that began late last year is posing as much of a challenge to research managers and administrators as to solid-state physicists. Their problem: How best to allocate scarce people, funds and equipment to take advantage of the new fervor in this sector of science, in which the maximum temperature at which resistance-free transmission of electric current occurs has soared. Although physicists warn that several technical hurdles remain, com

Written byPeter Gwynne
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Although physicists warn that several technical hurdles remain, companies are preparing to take advantage of these breakthroughs in the basic science. Paul Chu of the University of Houston said that more than 15 companies, large and small, had contacted him about investing in his work after he reported that his team, in collaboration with a group from the University of Alabama, had achieved superconductivity at 98 degrees K.

Companies with expertise in superconductivity are rapidly producing their own applications of the new findings. Researchers at IBM, whose Zurich Research Laboratory made the initial discovery that sparked the excitement, reported at last month's meeting here of the American Physical Society that they had made thin films of the new superconducting materials. Energy Conversion Devices, Inc. announced its development of a thin film that retains superconductivity at 80 degrees K. Stanford University researchers have also produced a thin film of superconducting oxide ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies